<DOC>
	<DOC>NCT00170755</DOC>
	<brief_summary>This study will evaluate the safety, tolerability and efficacy of darifenacin, in the long-term treatment of adult patients with overactive bladder.</brief_summary>
	<brief_title>A Long-Term Safety, Tolerability and Efficacy Study of Darifenacin in Adult Patients With Overactive Bladder</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder, Overactive</mesh_term>
	<mesh_term>Darifenacin</mesh_term>
	<criteria>Adult patients with overactive bladder who completed a previous darifenacin shortterm trial. Patients capable of independent toileting and able of independently completing the patient diary. Patients in whom the use of anticholinergic drugs was contraindicated Evidence of severe liver disease Patients with other clinically significant urinary or gynecological conditions Other protocoldefined inclusion/exclusion criteria may apply.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Overactive Bladder, incontinence, antimuscarinic, darifenacin, long-term treatment</keyword>
</DOC>